» Articles » PMID: 12829453

Nasal Airway Ion Transport and Lung Function in Young People with Cystic Fibrosis

Overview
Specialty Critical Care
Date 2003 Jun 28
PMID 12829453
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

There is strong evidence that abnormal airway ion transport is the primary defect that initiates the pathophysiology of lung disease in cystic fibrosis (CF). To examine the relationship between airway ion transport abnormality and severity of lung disease, we measured nasal potential difference in 51 young people with CF using a validated modified technique. There was no correlation between any component of the ion transport measurement and clinical condition (respiratory function, chest radiograph score, or Shwachman clinical score). Thirty subjects, homozygous for the DeltaF508 mutation, were divided into those above and those below average respiratory function for their age. There was no significant difference in any of the ion transport parameters between those with above and below average pulmonary function. Of the 51 subjects, 10 had significant hyperpolarization after perfusion with a zero Cl- solution (> 5 mV). This Cl- secretory capacity did not correlate with above average lung function. These data do not support the assertion that the extent of lung disease in CF reflects the degree of ion transport abnormality. We suggest that although an ion transport abnormality initiates lung disease, other factors (e.g., environmental and genetic modifiers) are more influential in determining disease severity.

Citing Articles

Investigating the role of CFTR in human and mouse myometrium.

Prendergast C, Wray S, Dungate D, Martin C, Vaida A, Brook E Curr Res Physiol. 2024; 7:100122.

PMID: 38501132 PMC: 10945125. DOI: 10.1016/j.crphys.2024.100122.


Repeatability and Diagnostic Value of Nasal Potential Difference in a Genetically Admixed Population.

Sad I, Higa L, Leal T, Martins R, de Almeida A, Ramos E J Clin Med Res. 2015; 8(1):15-24.

PMID: 26668678 PMC: 4676341. DOI: 10.14740/jocmr2312w.


Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control study.

Bagheri-Hanson A, Nedwed S, Rueckes-Nilges C, Naehrlich L BMC Pulm Med. 2014; 14:156.

PMID: 25280757 PMC: 4199064. DOI: 10.1186/1471-2466-14-156.


Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.

Accurso F, Van Goor F, Zha J, Stone A, Dong Q, Ordonez C J Cyst Fibros. 2014; 13(2):139-47.

PMID: 24660233 PMC: 4102431. DOI: 10.1016/j.jcf.2013.09.007.


Measurements of CFTR-mediated Cl- secretion in human rectal biopsies constitute a robust biomarker for Cystic Fibrosis diagnosis and prognosis.

Sousa M, Servidoni M, Vinagre A, Ramalho A, Bonadia L, Felicio V PLoS One. 2012; 7(10):e47708.

PMID: 23082198 PMC: 3474728. DOI: 10.1371/journal.pone.0047708.